For: | Sanai FM, Abaalkhail F, Hasan F, Farooqi MH, Nahdi NA, Younossi ZM. Management of nonalcoholic fatty liver disease in the Middle East. World J Gastroenterol 2020; 26(25): 3528-3541 [PMID: 32742124 DOI: 10.3748/wjg.v26.i25.3528] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v26/i25/3528.htm |
Number | Citing Articles |
1 |
Soraiya Ebrahimpour-Koujan, Amir Ali Sohrabpour, Edward Giovannucci, Akram Vatannejad, Ahmad Esmaillzadeh. Effects of vitamin D supplementation on liver fibrogenic factors, vitamin D receptor and liver fibrogenic microRNAs in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: an exploratory randomized clinical trial. Nutrition Journal 2024; 23(1) doi: 10.1186/s12937-024-00911-x
|
2 |
Bing Yang, Xi Yang, Xumei Tan, Liqing Lu, Wei Fan, Lucía Barbier-Torres, Justin Steggerda, Ting Liu, Heping Yang, Alessandro Granito. Regulatory Networks, Management Approaches, and Emerging Treatments of Nonalcoholic Fatty Liver Disease. Canadian Journal of Gastroenterology and Hepatology 2022; 2022: 1 doi: 10.1155/2022/6799414
|
3 |
Janus Ong, Khalid Alswat, Saeed Hamid, Mohamed El-Kassas. Nonalcoholic Fatty Liver Disease in Asia, Africa, and Middle East Region. Clinics in Liver Disease 2023; 27(2): 287 doi: 10.1016/j.cld.2023.01.014
|
4 |
M. Jawad Hashim, S. Sadaf Rizvi, Gulfaraz Khan. Liver Cancer in the Middle East. 2021; : 101 doi: 10.1007/978-3-030-78737-0_6
|
5 |
Quentin M. Anstee, Kate Hallsworth, Niall Lynch, Adrien Hauvespre, Eid Mansour, Sam Kozma, John-Paul Marino, Juliana Bottomley, James Piercy, Victoria Higgins. Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions. JHEP Reports 2022; 4(1): 100411 doi: 10.1016/j.jhepr.2021.100411
|
6 |
Reine Kanaan, Cesar Yaghi, Carole Saade Riachy, Anders Schlosser, Aline Hamade, Uffe Holmskov, Myrna Medlej‐Hashim, Grith Lykke Sørensen, Rania Jounblat. Serum MFAP4, a novel potential biomarker for liver cirrhosis screening, correlates with transient elastography in NAFLD patients. JGH Open 2023; 7(3): 197 doi: 10.1002/jgh3.12873
|
7 |
Arpita Das, Yu Lung Malcolm Tang, Nora A. Althumiri, Vanessa Garcia-Larsen, Jörn M. Schattenberg, Saleh A. Alqahtani. Fatty acid composition but not quantity is an important indicator of non-alcoholic fatty liver disease: a systematic review. European Journal of Clinical Nutrition 2023; 77(12): 1113 doi: 10.1038/s41430-023-01335-2
|
8 |
HenryH Nguyen, SamuelS Lee. Fluctuating hepatitis B viremia: Full of sound and fury, signifying nothing?. Saudi Journal of Gastroenterology 2022; 28(5): 319 doi: 10.4103/sjg.sjg_307_22
|
9 |
Pegah Golabi, James M. Paik, Saleh AlQahtani, Youssef Younossi, Gabriela Tuncer, Zobair M. Younossi. Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019. Journal of Hepatology 2021; 75(4): 795 doi: 10.1016/j.jhep.2021.05.022
|
10 |
Ashwaq Alolyan, Kanan Alshammari, Mohammad Arabi, Ahmed Alshehri, Hamad Alsuhaibani, Fahad Ibnshamsah, Abdullah Alsharm, Mervat Mahrous, Adnan Al Zanbagi, Mazen Hassanain, Shouki Bazarbashi. Treatment Patterns and Recommendations for Improving the Management of Hepatocellular Carcinoma in Saudi Arabia. Journal of Hepatocellular Carcinoma 2024; : 349 doi: 10.2147/JHC.S442842
|
11 |
Huilong Chen, Yuan Zhan, Jinxiang Zhang, Sheng Cheng, Yuhao Zhou, Liyuan Chen, Zhilin Zeng. The Global, Regional, and National Burden and Trends of NAFLD in 204 Countries and Territories: An Analysis From Global Burden of Disease 2019. JMIR Public Health and Surveillance 2022; 8(12): e34809 doi: 10.2196/34809
|